ANI Pharmaceuticals Shares Rise After Earnings Report and FDA Approval
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) stock jumped more than 40% on Monday after the pharma Company announced business highlights and financial results for the three months ended September 30, 2021. Autoimmune FDA Approval According to the Company has accomplished important...